Commissioning Guide - Antenatal and postnatal mental health services (August 2008)
This commissioning guide provides support for the local implementation of NICE clinical guidelines through commissioning, and is a resource to help health professionals in England to commission effective antenatal and postnatal mental health services.
Commissioning Guide
Breast cancer (early and locally advanced): draft guideline consultation (13th August 2008)
A clinical practice guideline on Breast cancer (early & locally advanced) is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th October 2008.
Full Draft Guideline
NICE Draft Guideline
Evidence Review
Needs Assessment
Comments Proforma
Breast cancer (advanced): consultation on the draft guidance (13th August 2008)
A clinical practice guideline on Breast cancer (advanced) is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th October 2008.
Full Draft Guideline
NICE Draft Guideline
Evidence Review
Needs Assessment
Comments Proforma
Promoting Physical Activity for children: consultation on the draft guidance (18th August 2008)
Consultation on the draft guidance relating to Promoting physical activity, active play and sport for pre-school and school age children in family, pre-school, school and community settings. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. Closing date for comments is 16th September 2008.
Consultation
Management of long-term sickness and absence and incapacity for work: consultation on the draft guidance (20th August 2008)
Consultation on the draft guidance for primary care and employers on the management of long term sickness and incapacity. This consultation will take place between 20 August - 17 September 2008.
Draft Guidance
Comments Form
Insertion of mesh uterine suspension sling (including sacrophysteropexy) for uterine prolapse repair: interventional procedures consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining the insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about the insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Infracoccygeal sacropexy using mesh for uterine prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining infracoccygeal sacropexy using mesh for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about infracoccygeal sacropexy using mesh for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Infracoccygeal sacropexy using mesh for vaginal vault prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining infracoccygeal sacropexy using mesh for vaginal vault prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE’s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about infracoccygeal sacropexy using mesh for vaginal vault prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Sacrocolpopexy using mesh for uterine prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining sacrocolpopexy using mesh for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE?s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about sacrocolpopexy using mesh for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Sacrocolpopexy using mesh for vaginal vault prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining sacrocolpopexy using mesh for vaginal vault prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE?s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about sacrocolpopexy using mesh for vaginal vault prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Pain (chronic neuropathic or ischaemic) - spinal cord stimulation: final appraisal determination (1st September 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Pain (chronic neuropathic or ischaemic) - spinal cord stimulation and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 15th September 2008.
Final Appraisal Determination
Table of comments on ACD
Consultee and Commentator Comments
Expert Comments on the ACD
Abdominal aortic aneurysm - endovascular stent-grafts: appraisal consultation (2nd September 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of endovascular stent–grafts and provide guidance on their use to the NHS in England. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of endovascular stent–grafts. Closing date for comments is 22nd September 2008.
Consultation
Evaluation Report
Hearing impairment - cochlear implants: final appraisal determination (2nd September 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Cochlear implants for severe to profound deafness in children and adults and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 16 September 2008.
Final Appraisal Determination
Response to Consultee, Commentator and Public Comments on the ACD
Consultee and Commentator Comments on the ACD
Expert comments on the ACD
Identification and management of familial hypercholesterolaemia Clinical Guideline CG71 (27th August 2008)
The advice in the NICE guideline covers the care and treatment of adults and children/young people with familial hypercholesterolaemia (a specific type of inherited high cholesterol that runs in the family). It does not cover other forms of hypercholesterolaemia that are not genetic (inherited) or that are due to other genetic conditions.
Full Guideline and Appenices A - G
NICE Guideline
Quick Reference Guide
Understanding NICE Guidance
Costing Template
Costing Report
Entecavir for the treatment of chronic hepatitis B Technology Appraisal TA153 (27th August 2008)
Entecavir is recommended as a possible treatment for people with chronic hepatitis B.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Costing Statement
Audit Support
Telbivudine for the treatment of chronic hepatitis B Technology Appraisal TA154 (27th August 2008)
Telbivudine is not recommended for people with chronic hepatitis B. Healthcare professionals should not stop prescribing telbivudine for people who were already taking it when the guidance was issued. These patients should be able to carry on taking telbivudine until they and their healthcare professionals decide that it is the right time to stop treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Statement
This commissioning guide provides support for the local implementation of NICE clinical guidelines through commissioning, and is a resource to help health professionals in England to commission effective antenatal and postnatal mental health services.
Commissioning Guide
Breast cancer (early and locally advanced): draft guideline consultation (13th August 2008)
A clinical practice guideline on Breast cancer (early & locally advanced) is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th October 2008.
Full Draft Guideline
NICE Draft Guideline
Evidence Review
Needs Assessment
Comments Proforma
Breast cancer (advanced): consultation on the draft guidance (13th August 2008)
A clinical practice guideline on Breast cancer (advanced) is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 8th October 2008.
Full Draft Guideline
NICE Draft Guideline
Evidence Review
Needs Assessment
Comments Proforma
Promoting Physical Activity for children: consultation on the draft guidance (18th August 2008)
Consultation on the draft guidance relating to Promoting physical activity, active play and sport for pre-school and school age children in family, pre-school, school and community settings. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. Closing date for comments is 16th September 2008.
Consultation
Management of long-term sickness and absence and incapacity for work: consultation on the draft guidance (20th August 2008)
Consultation on the draft guidance for primary care and employers on the management of long term sickness and incapacity. This consultation will take place between 20 August - 17 September 2008.
Draft Guidance
Comments Form
Insertion of mesh uterine suspension sling (including sacrophysteropexy) for uterine prolapse repair: interventional procedures consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining the insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about the insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Infracoccygeal sacropexy using mesh for uterine prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining infracoccygeal sacropexy using mesh for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE's Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about infracoccygeal sacropexy using mesh for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Infracoccygeal sacropexy using mesh for vaginal vault prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining infracoccygeal sacropexy using mesh for vaginal vault prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE’s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about infracoccygeal sacropexy using mesh for vaginal vault prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Sacrocolpopexy using mesh for uterine prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining sacrocolpopexy using mesh for uterine prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE?s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about sacrocolpopexy using mesh for uterine prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Sacrocolpopexy using mesh for vaginal vault prolapse repair: interventional procedure consultation document (27th August 2008)
The National Institute for Health and Clinical Excellence (NICE) is examining sacrocolpopexy using mesh for vaginal vault prolapse repair and will publish guidance on its safety and efficacy to the NHS in England, Wales, Scotland and Northern Ireland. NICE?s Interventional Procedures Advisory Committee has considered the available evidence and the views of Specialist Advisers, who are consultants with knowledge of the procedure. The Advisory Committee has made provisional recommendations about sacrocolpopexy using mesh for vaginal vault prolapse repair. Closing date for comments is 24th September 2008.
Consultation
Pain (chronic neuropathic or ischaemic) - spinal cord stimulation: final appraisal determination (1st September 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Pain (chronic neuropathic or ischaemic) - spinal cord stimulation and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 15th September 2008.
Final Appraisal Determination
Table of comments on ACD
Consultee and Commentator Comments
Expert Comments on the ACD
Abdominal aortic aneurysm - endovascular stent-grafts: appraisal consultation (2nd September 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a multiple technology appraisal of endovascular stent–grafts and provide guidance on their use to the NHS in England. The Appraisal Committee has had its first meeting to consider both the evidence submitted and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of endovascular stent–grafts. Closing date for comments is 22nd September 2008.
Consultation
Evaluation Report
Hearing impairment - cochlear implants: final appraisal determination (2nd September 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Cochlear implants for severe to profound deafness in children and adults and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 16 September 2008.
Final Appraisal Determination
Response to Consultee, Commentator and Public Comments on the ACD
Consultee and Commentator Comments on the ACD
Expert comments on the ACD
Identification and management of familial hypercholesterolaemia Clinical Guideline CG71 (27th August 2008)
The advice in the NICE guideline covers the care and treatment of adults and children/young people with familial hypercholesterolaemia (a specific type of inherited high cholesterol that runs in the family). It does not cover other forms of hypercholesterolaemia that are not genetic (inherited) or that are due to other genetic conditions.
Full Guideline and Appenices A - G
NICE Guideline
Quick Reference Guide
Understanding NICE Guidance
Costing Template
Costing Report
Entecavir for the treatment of chronic hepatitis B Technology Appraisal TA153 (27th August 2008)
Entecavir is recommended as a possible treatment for people with chronic hepatitis B.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Costing Statement
Audit Support
Telbivudine for the treatment of chronic hepatitis B Technology Appraisal TA154 (27th August 2008)
Telbivudine is not recommended for people with chronic hepatitis B. Healthcare professionals should not stop prescribing telbivudine for people who were already taking it when the guidance was issued. These patients should be able to carry on taking telbivudine until they and their healthcare professionals decide that it is the right time to stop treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Statement
Implantation of miniature lens systems for advanced age-related macular degeneration Interventional Procedure Guidance IPG272 (27th August 2008)
Age-related macular degeneration is an eye disorder that usually starts later in life and causes problems with central vision. In this procedure, a combination of artificial lenses is implanted behind the pupil of one eye. The aim is that the implanted lenses help improve central vision while the other eye is used for peripheral vision.
Guidance
Understanding NICE Guidance
Audit Support
Consultation Comments
Macular degeneration (age-related) - ranibizumab and pegaptanib Technology Appraisal TA155 (27th August 2008)
Ranibizumab is recommended as a possible treatment for people with wet AMD if all the following apply to their eye: The best possible visual acuity after correction with glasses or contact lenses is between 6/12 and 6/96; There is no permanent damage to the fovea (the part of the eye that helps people to see things in sharp detail); The area affected by AMD is no larger than 12 times the size of the area inside the eye where the optic nerve connects to the retina; and There are signs that the condition has been getting worse. Pegaptanib is not recommended for people with wet AMD. Healthcare professionals should not immediately stop prescribing pegaptanib for people who were already taking it when the guidance was issued. These people should be able to carry on taking pegaptanib until they and their healthcare professionals decide that it is the right time to stop treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Cost Template
Pregnancy (rhesus negative women) - routine anti-D (review) (27th August 2008)
Routine antenatal anti-D prophylaxis is recommended as a treatment option for all pregnant women who are RhD negative and who are not known to be 'sensitised'. When a decision has been made to give routine antenatal anti-D prophylaxis, the treatment with the lowest cost should be used. This should take into account the costs of both obtaining and giving the treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Statement
Technical patient safety solutions for ventilator - associated pneumonia in adults Patient Safety Solutions Pilot Guidance PSG002 (27th August 2008)
The NICE guidance covers patients who are on a ventilator and have a tube placed into their mouth, nose or through the neck and down into their windpipe. Healthcare professionals should: make sure these patients are sitting up or leaning back supported for as much of the time as possible. This will not be appropriate for all patients (for example, those with injuries to the spine); and make sure an antiseptic is included as part of the mouth care routine for these patients.
Guidance
Understanding NICE Guidance
Costing Statement
Audit Support
Slide Set
Total Wrist Replacement Interventional Procedure Guidance IPG271 (27th August 2008)
Arthritis is a condition that causes swelling and damage to the cartilage and bone around the joints, including the wrist. It is painful and can reduce the function of the joint. Total wrist replacement aims to create an artificial wrist joint consisting of metal implants attached to the end of the arm and to the hand, separated by a spacer to allow movement of the hand.
Guidance
NICE Guidance
Age-related macular degeneration is an eye disorder that usually starts later in life and causes problems with central vision. In this procedure, a combination of artificial lenses is implanted behind the pupil of one eye. The aim is that the implanted lenses help improve central vision while the other eye is used for peripheral vision.
Guidance
Understanding NICE Guidance
Audit Support
Consultation Comments
Macular degeneration (age-related) - ranibizumab and pegaptanib Technology Appraisal TA155 (27th August 2008)
Ranibizumab is recommended as a possible treatment for people with wet AMD if all the following apply to their eye: The best possible visual acuity after correction with glasses or contact lenses is between 6/12 and 6/96; There is no permanent damage to the fovea (the part of the eye that helps people to see things in sharp detail); The area affected by AMD is no larger than 12 times the size of the area inside the eye where the optic nerve connects to the retina; and There are signs that the condition has been getting worse. Pegaptanib is not recommended for people with wet AMD. Healthcare professionals should not immediately stop prescribing pegaptanib for people who were already taking it when the guidance was issued. These people should be able to carry on taking pegaptanib until they and their healthcare professionals decide that it is the right time to stop treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Cost Template
Pregnancy (rhesus negative women) - routine anti-D (review) (27th August 2008)
Routine antenatal anti-D prophylaxis is recommended as a treatment option for all pregnant women who are RhD negative and who are not known to be 'sensitised'. When a decision has been made to give routine antenatal anti-D prophylaxis, the treatment with the lowest cost should be used. This should take into account the costs of both obtaining and giving the treatment.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Statement
Technical patient safety solutions for ventilator - associated pneumonia in adults Patient Safety Solutions Pilot Guidance PSG002 (27th August 2008)
The NICE guidance covers patients who are on a ventilator and have a tube placed into their mouth, nose or through the neck and down into their windpipe. Healthcare professionals should: make sure these patients are sitting up or leaning back supported for as much of the time as possible. This will not be appropriate for all patients (for example, those with injuries to the spine); and make sure an antiseptic is included as part of the mouth care routine for these patients.
Guidance
Understanding NICE Guidance
Costing Statement
Audit Support
Slide Set
Total Wrist Replacement Interventional Procedure Guidance IPG271 (27th August 2008)
Arthritis is a condition that causes swelling and damage to the cartilage and bone around the joints, including the wrist. It is painful and can reduce the function of the joint. Total wrist replacement aims to create an artificial wrist joint consisting of metal implants attached to the end of the arm and to the hand, separated by a spacer to allow movement of the hand.
Guidance
NICE Guidance
No comments:
Post a Comment